<?xml version="1.0" encoding="UTF-8"?>
<p>To date, there are no standardized antimicrobial prophylactic practices in patients undergoing CTI for B-ALL. However, we have made several observations. First, our study found that there were no cases of 
 <italic>Pneumocystis jiroveci</italic> pneumonitis and rare herpetic viral reactivations. Nearly all viral infections were due to respiratory viruses, occurring late after CTI, at a median of 48 days.
</p>
